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AbstrAct
Objectives The provision of complex surgery is 
increasingly centralised to high-volume (HV) specialist 
hospitals. Evidence to support nephrectomy centralisation 
however has been inconsistent. We conducted a 
systematic review and meta-analysis to determine 
the association between hospital case volumes and 
perioperative outcomes in radical nephrectomy, 
partial nephrectomy and nephrectomy with venous 
thrombectomy.
Methods Medline, Embase and the Cochrane Library were 
searched for relevant studies published between 1990 and 
2016. Pooled effect estimates for nephrectomy mortality 
and complications were calculated for each nephrectomy 
type using the DerSimonian and Laird random-effects 
model. Sensitivity analyses were performed to examine 
the effects of heterogeneity on the pooled effect estimates 
by excluding studies with the heaviest weighting, lowest 
methodological score and most likely to introduce bias 
from misclassification of standardised hospital volume.
results Some 226 372 patients from 16 publications 
were included in our review and meta-analysis. 
Considerable between-study heterogeneity was noted 
and only a few reported volume–outcome relationships 
specifically in partial nephrectomy or nephrectomy with 
venous thrombectomy. HV hospitals were correlated 
with a 26% and 52% reduction in mortality for radical 
nephrectomy (OR 0.74, 95% CI 0.61 to 0.90, p<0.01) and 
nephrectomy with venous thrombectomy (OR 0.48, 95% CI 
0.29 to 0.81, p<0.01), respectively. In addition, radical 
nephrectomy in HV hospitals was associated with an 18% 
reduction in complications (OR 0.82, 95% CI 0.73 to 0.92, 
p<0.01). No significant volume–outcome relationship 
in mortality (OR 0.84, 95% CI 0.31 to 2.26, p=0.73) or 
complications (OR 0.85, 95% CI 0.55 to 1.30, p=0.44) was 
observed for partial nephrectomy.
conclusions Our findings suggest that patients 
undergoing radical nephrectomy have improved outcomes 
when treated by HV hospitals. Evidence of this in partial 
nephrectomy and nephrectomy with venous thrombectomy 
is however not yet clear and could be secondary to the low 
number of studies included and the small patient number 
in our analyses. Further investigation is warranted to 
establish the full potential of nephrectomy centralisation 
particularly as existing evidence is of low quality with 
significant heterogeneity.
IntrOductIOn
In recent years, there has been an emerging 
trend for the centralisation of complex oper-
ations in healthcare systems around the 
world.1–3 This shift is supported by the growing 
research and evidence suggesting that hospi-
tals and surgeons with high caseloads have 
better patient outcomes.4–8 Proponents argue 
that centralisation allows more effective use 
of clinical expertise and specialist equip-
ment, and the increased exposure improves 
surgical skills and provides better training 
opportunities. Centralisation can also facili-
tate quicker adoption of care pathways, such 
as enhanced recovery, and may have more 
long-term financial sustainability for hospi-
tals. However, surgical centralisation requires 
further travel distance and limits patient 
choice when many would prefer to undergo 
surgery locally even if greater mortality risks 
are taken into consideration.9 Differences in 
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Research
strengths and limitations of this study
 ► This is a contemporary systematic review and meta-
analysis of the associations between hospital case 
volumes and nephrectomy outcomes.
 ► Sixteen primary studies, which is fourfold greater 
in number than previous meta-analyses, were 
used to synthesise the pooled effect estimates for 
nephrectomy mortality and complications.
 ► To the best of our knowledge, this is the first study to 
date to stratify analyses based on nephrectomy type 
to account for differences in technical complexity 
and rates of adverse outcomes.
 ► Current evidence in nephrectomy outcome–volume 
relationship is of low  quality and considerable 
heterogeneity exists between studies in design, type 
of data used, outcomes measured and statistical 
methodologies.
 ► Our study highlights the limitations in existing 
evidence and suggests questions that should be 
addressed in future research.
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disease biology, surgical complexity and rate of adverse 
outcomes may also limit the perceived benefits of central-
isation. Such a health service model may therefore not be 
appropriate for all conditions and operations.
Renal cancer accounts for over 2% of all new cancer 
diagnoses worldwide affecting more than 330 000 individ-
uals annually.10 Widespread use of cross-sectional imaging 
and increasing prevalence of obesity have contributed to 
a rising renal cancer incidence in many countries.11–13 
Despite recent developments in systemic therapies, 
nephrectomy is often considered the only potentially 
curative treatment for renal cancer, and the number of 
nephrectomies being performed is likely to increase as a 
result. It is, therefore, critical that health service providers 
understand the effects that organisational changes may 
have on patient outcomes. While there has been an 
expansion of volume–outcome research, no consensus 
has so far been reached on the efficacy of centralising 
nephrectomy, and many uncertainties remain about 
its potential benefits particularly as radical and partial 
nephrectomy carry different surgical complexities and 
outcomes.14 15 We present a contemporary systematic 
review and meta-analysis of the published literature 
on the association between hospital case volumes and 
perioperative outcomes stratified by nephrectomy types. 
We hypothesise that outcomes significantly improve with 
higher nephrectomy case volumes.
MethOds
Search criteria and data extraction
The systematic review and meta-analysis was reported in 
accordance to the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses (PRISMA) guidelines 
(online supplementary appendix 1).16 Medical subject 
heading terms and key words for nephrectomy, case 
volume and outcomes were used in Medline, Embase 
and the Cochrane Library to search for relevant studies 
published between January 1990 and December 2016 
(online supplementary appendix 2). Studies published 
prior to 1990 were not considered as recent medical and 
surgical advancements would have limited their appli-
cability to the modern healthcare system. Only studies 
published in English were considered as the risk of poten-
tial language bias associated with this exclusion generally 
has little effect on summary effect estimates.17 References 
were searched manually for additional relevant studies.
We included studies that presented original data in full-
texts on adult nephrectomy outcomes across two or more 
hospital case volume categories. Abstracts, case reports 
and review articles were excluded(online supplementary 
appendix 3). No restriction was set on the study design 
and both prospective and retrospective studies were 
considered. Only those describing the volume–outcome 
relationships in radical nephrectomy with or without 
venous thrombectomy and/or partial nephrectomy were 
eligible. Paediatric cohorts were excluded as were articles 
comprised solely of nephroureterectomy or nephrectomy 
for non-oncological indications. Restriction on the 
reported outcomes was only applied at the end stage of 
the search to enable assessment of the current published 
evidence. Only studies reporting nephrectomy mortality 
and complications were included in the final analysis.
Two investigators (RCJH and JM) independently 
reviewed all studies for inclusion, data extraction and 
methodological quality. Any disagreement between the 
two reviewers was resolved by discussion and consul-
tation with a third reviewer (JNA). Where only rates of 
outcomes were presented, these were applied to the case 
number to give the number of events, within the error of 
the published results. Study authors were contacted for 
further clarification if specific rates of outcomes and case 
numbers were not published.18 19
As the cut-off values for hospital case volume categories 
differed among studies, we used the approach adopted 
by similar previous meta-analyses by dichotomising the 
volume groups presented by each study into low volume 
(LV) and high volume (HV) when the article presented 
an even number of volume groupings.20 21 If a study 
presented an odd number of volume groups, the middle 
group was considered as LV.
Methodological quality and potential risk of bias were 
scored using a 10-domain system designed to measure 
the degree in which the study is likely to reveal gener-
alisable conclusion about the magnitude and nature of 
the volume–outcome relationship.22 23 Each domain 
provides a score between 0 and 3 with a total maximum 
of 18, suggesting a well-designed study. The param-
eters included the representativeness of the sample, 
the number of hospitals analysed, the samples size, the 
number of adverse events recorded, the appropriate-
ness of patient selection, the number of volume catego-
ries examined, the number of outcomes measured, the 
degree of risk adjustment performed, whether hospital 
and surgeon case volumes were analysed in conjunction 
and whether clinical processes of care were measured.
If studies extracted data from the same source with over-
laps in the study periods, we employed the following rules 
to avoid duplicating populations: (1) studies with iden-
tical patient cohort but examining different outcomes 
were considered and analysed separately, (2) studies that 
derived data from older datasets were excluded in favour 
of the more contemporary cohort, (3) if the above rules 
were not applicable, studies with the lower methodolog-
ical quality scores were excluded and (4) where quality 
scores were equal, the study covering the longest period 
was included.
Quantitative data synthesis
All statistical analyses were performed using Stata 14.24 
Nephrectomy types were categorised into radical nephrec-
tomy, partial nephrectomy and nephrectomy with venous 
thrombectomy and analysed separately. Studies involving 
multiple types of nephrectomies were analysed based on 
the aforementioned groups, but if this was not feasible, 
they were categorised as radical nephrectomy. With the 
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assumption that a distribution of effects exists among 
studies, all pooled effect size were calculated using the 
DerSimonian and Laird random-effects model, which 
provided more conservative estimates compared with 
fixed-effect model. OR and 95% CI were calculated and 
presented for each outcome measure using LV groups as 
the reference.
When the meta-analysis demonstrated significantly 
better outcomes in HV hospitals, we quantified the clin-
ical effectiveness of centralisation by calculating the 
numbers needed to treat, or in our case numbers needed 
to centralise (NNC). NNC represents the number of cases 
that will need to be centralised from LV hospitals and 
treated by HV hospitals in order to prevent one adverse 
event.
heterogeneity
As the DerSimonian and Laird model would have only 
accounted for some between-study heterogeneity, we 
further quantified heterogeneity by calculating I2 statistic. 
I2 provides an easily understood number, which describes 
the proportion of total variation in estimates that is due 
to heterogeneity rather than chance.25 Values of 25% or 
lower denote low heterogeneity and values of 75% or 
greater denote considerable heterogeneity.26 Meta-regres-
sion was performed to explore the influence of potential 
explanatory variables on heterogeneity including each 
study’s publication year, country, data source, number 
of patients and their demographics, number of hospitals 
and threshold for HV hospitals.
Publication bias
Funnel plots were generated to investigate potential 
publication bias, and were enhanced to include contours 
that divide the funnel into statistically significant and 
non-significant areas. Funnel plot symmetry suggests 
low probability of publication bias and Harbord’s modi-
fied test was used to test for asymmetry.27 Harbord’s 
test reduces false positive rates when applied to binary 
outcome data, especially when there is low between-study 
heterogeneity.
Trim and fill method was also performed to account for 
publication bias by adjusting the meta-analysis to incorpo-
rate the theoretically missing studies.28
sensitivity analysis
To examine specific studies’ effects on pooled effect size, 
sensitivity analyses were performed by excluding indi-
vidual studies and repeating the meta-analyses. We exam-
ined the effects of studies with the heaviest weighting and 
studies with the lowest methodological quality score. As 
there is currently no consensus on what nephrectomy case 
volume is necessary to be considered as HV, we repeated 
our analyses by excluding studies whose standardised HV 
categories overlapped most significantly with the stan-
dardised LV categories in other studies to account for 
potential bias of misclassifying volume categories in our 
dichotomy.
As secondary analyses, we additionally repeated the 
meta-analysis three further times with different methods 
of dichotomising the volume groups to examine whether 
our initial estimates would remain consistent. The 
methods of dichotomising were (1) lowest volume catego-
ries and all others, (2) even dichotomy and when studies 
present an odd number of volume categories, the middle 
group was considered as HV and (3) highest volume cate-
gories and all others.
results
Study selection and characteristics
From the 5680 articles initially identified, 16 were 
included in the systematic review containing 226 372 
patients from six countries (figure 1). For the meta-anal-
ysis, 11 studies with 201 506 patients examining radical 
nephrectomy were included while 4 studies of 23 617 
patients and 2 studies of 1249 patients examining partial 
nephrectomy and nephrectomy with venous thrombec-
tomy were included, respectively. Publication year ranged 
from 2002 to 2016, while cohort periods covered from 
1993 to 2013.
Table 1 summarises the characteristics of the included 
studies. Variations were observed in study designs 
including source of data and outcomes measured. Out 
of a maximum possible score of 18, the median quality 
score from the included studies was nine (IQR 8–9) with 
the majority of the studies failing to adequately address 
potential confounders including measuring the appro-
priateness of patient selection, adjusting for case-mix 
variations and accounting for differences in clinical risks 
and processes of care (online supplementary appendix 
4). Variable thresholds for HV hospitals were noted across 
the included studies.
Mortality and hospital volumes
Postoperative mortality, defined as inpatient or 30 day, 
was the most frequently examined outcome reported 
in 14 studies. Ten studies reported mortality in radical 
nephrectomy,18 29–37 three in partial nephrectomy36 38 39 
and two in nephrectomy with venous thrombectomy.19 40 
The overall mortality was 1.59% (range 0.20%–7.2%) with 
mortality rates in HV and LV hospitals being 1.47% and 
1.68%, respectively.
Radical nephrectomy
Meta-analysis demonstrated that patients who underwent 
radical nephrectomy in HV hospitals had a 26% reduction 
(OR 0.74, 95% CI 0.61 to 0.90, p<0.01) in postoperative 
mortality, corresponding to an NNC of 234 (figure 2A).
Significant heterogeneity was observed (I2=75.0%, 
p<0.01). Meta-regression was performed to investigate 
the potential explanatory variables for heterogeneity, and 
only differences in the threshold values for HV hospitals 
were shown to be a significant contributor (online supple-
mentary appendix 5A). Subgroup analysis of the three 
studies examining exclusively radical nephrectomies 
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Figure 1 Flow chart of the article selection process.
demonstrated a more pronounced reduction in postoper-
ative mortality favouring HV hospitals (OR 0.62, 95% CI 
0.53 to 0.71, p<0.01).18 34 36 This corresponded to a lower 
NNC of 166 with little residual heterogeneity (I2=0.0%, 
p=0.40). The overall funnel plot was visually asymmetrical 
particularly missing studies with effect estimates favouring 
LV hospitals (figure 3). However,  Harbord’s modified test 
did not show significant asymmetry (p=0.40) and ‘trim 
and fill’ method did not change the initial estimate, indi-
cating no clear evidence of publication bias. 
 In sensitivity analyses, exclusion of the most heavily 
weighted study led to a similar pooled-effect estimate (OR 
0.70, 95% CI 0.55 to 0.88, p<0.01).37 Exclusion of the study 
with the lowest quality score also did not significantly alter 
our result (OR 0.74, 95% CI 0.61 to 0.91, p<0.01).35 To 
examine the potential bias introduced by misclassification 
of hospital volume, two cohorts were excluded.30 31 35 This 
did not substantially change our pooled-effect estimate 
either (OR 0.73, 95% CI 0.58 to 0.93, p=0.01). Overall, 
radical nephrectomies in HV hospitals appeared to have 
significantly lower mortality.
Partial nephrectomy
Meta-analysis showed that partial nephrectomy patients 
operated in HV hospitals had a 16% reduction in 
postoperative mortality, but this was not statistically signif-
icant (OR 0.84, 95% CI 0.31 to 2.26, p=0.73) (figure 2B). 
Moderate but non-significant heterogeneity was noted 
(I2=36.84%, p=0.21). Sensitivity analyses removing studies 
with the heaviest weighting39 or most likely to introduce 
misclassification bias of exposure38 demonstrated reduced 
mortality favouring HV hospitals, but these remained 
non-significant.
Nephrectomy with venous thrombectomy
Patients who underwent nephrectomy with venous 
thrombectomy in HV hospitals had a 52% reduction 
(OR 0.48, 95% CI 0.29 to 0.81, p<0.01) in short-term 
mortality compared with LV hospitals (figure 2C). This 
corresponded to an NNC of 25 with low heterogeneity 
(I2=0.0%, p=0.50). Due to the small number of studies 
reporting this outcome, further testing of heterogeneity 
and publication bias was not expected to generate mean-
ingful results and this was not attempted.
complications and hospital volumes
Complication was the second most frequently investi-
gated outcome, reported in 11 studies. Events consid-
ered as a complication differed among studies (table 1). 
Seven studies reported complications in radical 
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Figure 2 Forest plots displaying the pooled effect estimates of nephrectomy mortality in high-volume and low-volume 
hospitals for (A) radical nephrectomy, (B) partial nephrectomy and (C) nephrectomy with venous thrombectomy. 
nephrectomy18 30 31 33–35 41 and three in partial nephrec-
tomy.38 39 42 Only one study examined volume–outcome 
relationship in nephrectomy with venous thrombectomy 
and meta-analysis was, therefore, not appropriate.40 The 
overall complication rate was 16.26% (range 7.4%–78%). 
HV hospitals had complication rates of 15% compared 
with 17.51% in LV hospitals.
Radical nephrectomy
Meta-analysis showed an 18% reduction (OR 0.82, 95% CI 
0.73 to 0.92, p<0.01) in nephrectomy complications in 
HV centres, corresponding to an NNC of 38 (figure 4A). 
Significant heterogeneity was noted (I2=76.25%, p<0.01), 
but none of the factors examined in meta-regression 
significantly contributed to this (online supplementary 
appendix 5B). Sensitivity analyses by removing studies 
with the lowest quality41 or most likely to introduce 
misclassification bias of exposure35 41 did not signifi-
cantly alter our initial result. Excluding study with the 
heaviest weighting however led to a loss of significance 
in the pooled-effect estimate, which however still demon-
strated a 11% reduction in complications in HV hospitals 
(OR 0.89, 95% CI 0.74 to 1.08, p=0.24). Overall, radical 
nephrectomies performed in HV hospitals appeared to 
have significantly lower complications compared with LV 
hospitals.
Partial nephrectomy
Partial nephrectomy patients operated in HV hospitals 
had a 15% reduction in complications, but this was not 
statistically significant (OR 0.85, 95% CI 0.55 to 1.30, 
p=0.44) (figure 4B). Significant heterogeneity was noted 
(I2=94.80%, p<0.01). Sensitivity analysis by removing 
studies with the heaviest weighting42 or most likely to 
introduce misclassification bias of hospital volume38 did 
not result in significance.
secondary analyses using different methods for 
dichotomising hV and lV
As there is no consensus on what constituted HV hospi-
tals in current evidence, simple dichotomy of volume 
groups may introduce inherent bias to the estimates. Yet 
no recommendation on how best to proceed in volume–
outcome analysis presently exists.
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Figure 3 Contour-enhanced funnel plot of studies analysing hospital volume–outcome relationship in radical nephrectomy 
mortality. Harbord’s modified test for funnel plot asymmetry was not statistically significant.
Figure 4 Forest plots displaying the pooled effect estimates of nephrectomy complications in HV and LV hospitals for (A) 
radical nephrectomy and (B) partial nephrectomy.
In our secondary analyses, we consistently observed 
significantly lower risks of mortality for both radical 
nephrectomy and nephrectomy with venous throm-
becotmy in HV hospitals regardless how volumes were 
dichotomised (table 2). The magnitudes of risk reduc-
tions were more pronounced when higher thresholds 
for HV hospitals were considered particularly for radical 
nephrectomy mortality. Partial nephrectomy mortality 
however continued to demonstrate no significant associ-
ation to volume even when dichotomies were comparing 
the highest volume groups to all others.
Risks of radical nephrectomy complications remained 
significantly reduced in HV hospitals when the dichotomy 
threshold for HV hospitals was increased, but the signifi-
cance was lost when the thresholds were lowered. Associ-
ation between hospital volumes and partial nephrectomy 
complications remained insignificant regardless of how 
HV was defined in our dichotomy.
dIscussIOn
Evidence on volume–outcome relationships in complex 
diseases and procedures has increased substantially in 
recent years. Many operations have been shown to have 
improved outcomes in HV centres, but this may not be 
uniform across all surgeries and benefits have not been 
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Table 2 Results of meta-analysis by using different methods of dichotomising volume groups
Lowest volume 
group vs all others
Even dichotomy, 
middle group as HV
Even dichotomy,
middle group as LV
(primary analysis)
Highest volume group 
vs all others
Mortality
Radical nephrectomy OR: 0.82
95% CI 0.71 to 0.94, 
p=0.01
OR: 0.83
95% CI 0.72 to 
0.95, p<0.01
OR: 0.74
95% CI 0.61 to 
0.90, p<0.01
OR: 0.72
95% CI 0.61 to 
0.85, p<0.01
Partial nephrectomy OR: 0.48
95% CI 0.18 to 1.31, 
p=0.15
OR: 0.67
95% CI 0.17 to 2.75, 
p=0.58
OR: 0.84
95% CI 0.31 to 2.26, 
p=0.73
OR: 0.93
95% CI 0.31 to 2.77, 
p=0.90
Nephrectomy with venous 
thrombectomy
OR: 0.59
95% CI 0.35 to 0.99, 
p=0.045
OR: 0.46
95% CI 0.27 to 
0.80, p<0.01
OR: 0.48
95% CI 0.29 to 0.81, 
p=0.01
OR: 0.48
95% CI 0.25 to 0.92, 
p=0.03
Complications
Radical nephrectomy OR: 0.89
95% CI 0.78 to 1.01, 
p=0.07
OR: 0.84
95% CI 0.68 to 1.05, 
p=0.13
OR: 0.82
95% CI 0.73 to 
0.92, p<0.01
OR: 0.82
95% CI 0.73 to 
0.92, p<0.01
Partial nephrectomy OR: 0.82
95% CI 0.55 to 1.41, 
p=0.60
OR: 0.80
95% CI 0.47 to 1.36, 
p=0.40
OR: 0.85
95% CI 0.55 to 1.30, 
p=0.44
OR: 0.81
95% CI 0.53 to 1.24, 
p=0.33
HV, high volume; LV, low volume.
associated with volume in percutaneous nephrolitho-
tomy or appendicectomy.43–48 This meta-analysis provides 
a contemporary review of the effects of centralisation 
in nephrectomy outcomes. It reveals significant inverse 
associations between hospital case volumes for short-term 
mortality and complications for radical nephrectomy, but 
evidence of these for partial nephrectomy and nephrec-
tomy with venous thrombectomy remains less compelling.
Considered individually, all but three studies in our 
review reported lack of associations between hospital 
volume and nephrectomy mortality.29 36 37 However, such 
associations in favour of HV hospitals were apparent 
when considering the totality of the evidence particularly 
in radical nephrectomy and venous thrombectomy. This 
finding is consistent with the only other meta-analysis on 
nephrectomy volume–outcome relationship published in 
2009 but includes fourfold greater number of studies.23 
Our meta-analysis demonstrates that the mortality benefit 
seen in radical nephrectomy may be relatively small 
requiring centralisation of 234 patients in order to avoid 
one death. However, the NNC decreased considerably to 
166 in our sensitivity analyses. Coupled with the much 
lower NNC of 38 for radical nephrectomy complications, 
there is moderate evidence to support its centralisation.
In our analyses, the mortality reduction for venous 
thrombectomy was observed to be more pronounced 
than that in radical nephrectomy. This is consistent with 
the ‘practice-makes-perfect’ hypothesis particularly as 
venous thrombectomy is a technically more challenging 
procedure compared with radical nephrectomy, though 
interestingly a similar trend was not observed for partial 
nephrectomy.49 These results should however be inter-
preted taking into consideration that only a few studies 
have so far reported on the volume–outcome relation-
ships for partial nephrectomy and venous thrombectomy 
and the pooled effect estimates were synthesised from 
just two to three publications, thus the overall evidence 
is weak. As partial nephrectomy has only been widely 
adopted in the last two decades and nephrectomy central-
isation also a relatively recent phenomenon, it is likely 
that more evidence will emerge in the coming years and 
repeating the meta-analysis at such point is warranted.1 50 
This will be of particular importance as partial nephrec-
tomy has been demonstrated to be a safe procedure 
and the relatively small number of partial nephrectomy 
patients in our meta-analysis might not have been suffi-
ciently powered to reveal the true presence of a volume–
outcome relationship, as evident in our wide CI.51 This 
may also explain the lack of significant association 
between partial nephrectomy complications and hospital 
volumes. With its low mortality and morbidity rates, other 
outcome measures such as ischaemic time and negative 
surgical margins, are likely to be more appropriate quality 
markers in volume–outcome analysis, but these have so 
far been poorly evaluated.
Despite the strict inclusion criteria in our studies, 
we observed considerable heterogeneity, especially in 
the meta-analyses of nephrectomy complications. One 
explanation for this is the lack of standardised reporting 
of complications by individual studies. Harder endpoints 
as previously discussed could have overcome this. Other 
more objective outcomes including transfusion rate and 
length of stay were reported by four30 31 35 42 and seven 
studies30–32 34 38 42 52 in our systematic review, respectively, 
but they were not in adequate numbers to be stratified 
by nephrectomy types or in sufficiently detailed data to 
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perform meta-analyses. In addition, variations in the 
threshold values for HV hospitals likely contributed 
to the heterogeneity, although this was not evident in 
the meta-regression. Volume was also used as a proxy 
marker for surgical and care quality, but the precise 
clinical processes that may improve patient outcomes 
were not directly measured or identified. It is there-
fore conceivable for some heterogeneity to arise from 
these unmeasured practices. Results from the multiple 
sensitivity analyses to adjust for study differences have 
however remained robust and our study would still 
appear to be informative and relevant. There are other 
research designs that may be more appropriate in 
testing our hypothesis such as analysis of primary data 
amalgamated from multiple population cohorts. The 
considerable ethical concerns and logistical constraints 
of this may however be challenging to overcome and 
not practically feasible.
While there has been an expansion in the studies 
on nephrectomy volume–outcome relationship, many 
questions continue to be unanswered. The propor-
tion of nephrectomy performed under laparoscopy 
or robotic assistance is growing.53 54 There is however 
a paucity of evidence specifically investigating this 
in the volume–outcome context with only one study 
examining the differences in perioperative measures in 
robotic partial nephrectomy.42 Three other studies have 
adjusted surgical techniques in multivariable regres-
sions, but these did not directly demonstrate the effect 
of laparoscopic volumes on surgical outcomes.18 30 33 
Due to the small study number and data quality, it was 
not possible in this meta-analysis to further substratify 
each nephrectomy type into open and minimally inva-
sive and our results should be interpreted taking this 
limitation into account.
Tumour characteristics including TNM stage and 
grades are well established to significantly affect and 
predict nephrectomy mortality, but only two studies 
have so far adjusted for this in their analyses.18 29 
Surgeon case volume and degree of specialisation also 
play significant roles in determining operative outcome, 
and can be more important than hospital case volume 
alone.45 55–57 While not the focus of this study, no signif-
icant association was found between surgeon volume 
and complications in radical nephrectomy,18 but 31% 
and 16% reduction in mortality and complications 
respectively was observed in partial nephrectomy in 
HV surgeons.39 HV surgeons performing nephrectomy 
with venous thrombectomy were also reported to have 
reduced risk of mortality,19 but this was not observed 
in a subsequent study.40 As our analyses were based 
on crude pooled effect estimates, future meta-anal-
ysis should ideally attempt to adjust for other possible 
confounders including patient demographics, socio-
economic status and comorbidities, although this may 
be methodologically challenging. It would be of high 
interest to understand the interactions among patient 
characteristics, surgeon volume, surgical approach and 
oncological factors in the volume–outcome relationship 
and may provide additional insights to selecting patients 
that will benefit the most from nephrectomy centrali-
sation, such as those with multiple comorbidities or 
advanced disease. Similarly, no study has examined the 
long-term benefits of centralising nephrectomy when 
HV centres have been demonstrated to increase onco-
logical survival in other cancer surgeries.58 59 Results 
of this may further influence the recommendations 
for nephrectomy centralisation and this is currently 
being explored in our ongoing work. Other outcomes 
including long-term risks of chronic kidney disease 
and cardiovascular morbidities and patient reported 
outcome measures may also provide more relevant 
and holistic measurements of the potential efficacy of 
nephrectomy centralisation.
Our secondary analyses would suggest that a 
minimum volume threshold for nephrectomy likely 
exist, and beyond that, risks of adverse outcomes may 
continue to decrease with further increase in volume. 
An important limitation of this however is that this 
minimum threshold cannot be objectively determined 
from the current evidence. The specific care processes 
that may produce good outcomes, such as access to 
nurse specialists and clinical trials, could not be deter-
mined from our study. As volume is likely to be a proxy 
marker for quality, increasing volume alone in itself is 
unlikely to reduce adverse results.60 Future research 
should concentrate on identifying the qualitative differ-
ences between providers in order for the contributing 
good practices to be adopted by lesser performing 
centres.
cOnclusIOns
Current evidence of the association between hospital 
volumes and nephrectomy outcomes is of low quality 
with considerable between-study heterogeneity. Our 
meta-analyses demonstrated significant reductions in 
mortality and complications for patients undergoing 
radical nephrectomy in HV hospitals. Evidence of this 
in partial nephrectomy and nephrectomy with venous 
thrombectomy is not yet clear but warrants further 
investigations.
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